Managing Patient Refusal of PRBC Transfusion Due to Pulmonary Edema Concerns

Introduction to Transfusion Guidelines

The American College of Critical Care Medicine recommends transfusing if hemoglobin <7 g/dL in critically ill patients, as this threshold is supported by high-quality evidence showing no benefit from liberal transfusion strategies (Hb <10 g/dL) 2, 3
For patients with acute coronary syndromes, the American Heart Association suggests considering transfusion if Hb <8 g/dL on hospital admission 4, 3
During cardiopulmonary bypass, the American Society of Anesthesiologists recommends transfusing if hematocrit <18% (Hb 6.0 g/dL) 5

Severe anemia carries higher mortality risk than appropriately managed transfusion, particularly in patients with cardiovascular disease, according to the American College of Cardiology 4, 2
RBC transfusion increases oxygen delivery to tissues, which is critical in hemorrhagic shock and severe anemia, as stated by the American College of Critical Care Medicine 6
Pulmonary edema from transfusion (TACO) is preventable through proper administration techniques, including slow transfusion rates and prophylactic diuretics, as recommended by the American Association of Blood Banks 1

If patient has active pulmonary edema, do not transfuse until pulmonary edema is treated, unless there is life-threatening hemorrhagic shock, as advised by the American Thoracic Society 6
If patient has risk factors but no active edema, proceed with transfusion using preventive measures if hemoglobin meets transfusion thresholds, according to the American College of Critical Care Medicine 1

Administer prophylactic furosemide 20-40 mg IV before transfusion in patients with history of heart failure or previous TACO, as recommended by the American Heart Association 1
Transfuse slowly over 3-4 hours rather than standard 2 hours, or split units to minimize volume load, as suggested by the American Association of Blood Banks 1
Monitor continuously during transfusion - stop immediately if dyspnea or tachypnea develops, as advised by the American College of Critical Care Medicine 1

If hemoglobin >7 g/dL and patient is hemodynamically stable, consider alternative management strategies, such as administering IV fluids to achieve normovolemia, optimizing oxygen delivery through other means, and considering recombinant human erythropoietin for longer-term management, as recommended by the American Society of Clinical Oncology 2, 7, 3

Measure BNP or NT-proBNP before transfusion as baseline for comparison if respiratory symptoms develop, as suggested by the American Association of Blood Banks 1
Stop transfusion immediately if dyspnea or tachypnea occurs - these are early TACO symptoms, as advised by the American College of Critical Care Medicine 1
Do not fixate on hemoglobin numbers alone - always incorporate symptoms, comorbidities, and oxygen delivery assessment, as recommended by the American College of Critical Care Medicine 2, 3
Do not use "liberal" transfusion strategies (Hb <10 g/dL threshold) - these show no benefit and increase TACO risk, as stated by the American College of Critical Care Medicine 2, 3